(Q36452526)

14 August 2017

1 reference

title

Central nervous system biogenic amine targets for control of appetite and energy expenditure (English)

1 reference

14 August 2017

1 reference

David L Nelson

1

1 reference

14 August 2017

Donald R Gehlert

series ordinal

2

1 reference

14 August 2017

language of work or name

1 reference

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

29

1 reference

14 August 2017

1

1 reference

14 August 2017

49-60

1 reference

https://scigraph.springernature.com/pub.10.1385/endo:29:1:49

14 August 2017

0 references

cites work

Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters

1 reference

12 December 2020

Genetic and pharmacological aspects of histamine H3 receptor heterogeneity

1 reference

12 December 2020

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism

1 reference

12 December 2020

Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

1 reference

12 December 2020

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors

1 reference

12 December 2020

Current and potential drugs for treatment of obesity

1 reference

12 December 2020

Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs

1 reference

12 December 2020

The elusive alpha(1D)-adrenoceptor: molecular and cellular characteristics and integrative roles.

1 reference

12 December 2020

Molecular, pharmacological and functional diversity of 5-HT receptors

1 reference

12 December 2020

The histamine H4 receptor as a new therapeutic target for inflammation

1 reference

12 December 2020

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro

1 reference

12 December 2020

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

1 reference

12 December 2020

Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins

1 reference

12 December 2020

Meta-analysis: pharmacologic treatment of obesity

1 reference

12 December 2020

High constitutive activity of native H3 receptors regulates histamine neurons in brain.

1 reference

12 December 2020

Serotonin receptor ligands and the treatment of obesity

1 reference

12 December 2020

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis

1 reference

12 December 2020

Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain

1 reference

12 December 2020

Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats

1 reference

12 December 2020

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

1 reference

12 December 2020

Sibutramine: a review of the pharmacology of a novel anti-obesity agent

1 reference

12 December 2020

Brain histamine and feeding behavior

1 reference

12 December 2020

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

1 reference

12 December 2020

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

12 December 2020

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

12 December 2020

Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists

1 reference

12 December 2020

In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates

1 reference

12 December 2020

Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation.

1 reference

12 December 2020

Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine

1 reference

12 December 2020

Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat

1 reference

12 December 2020

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

1 reference

12 December 2020

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

The histamine H3 receptor: from gene cloning to H3 receptor drugs

1 reference

12 December 2020

Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors

1 reference

12 December 2020

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

1 reference

12 December 2020

Dopamine D3 receptor antagonists as therapeutic agents

1 reference

12 December 2020

Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.

1 reference

12 December 2020

The physiology of brain histamine.

1 reference

12 December 2020

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.

1 reference

12 December 2020

Influence of sibutramine on energy expenditure in African American women

1 reference

12 December 2020

Psychostimulants and monoamine transporters: upsetting the balance

1 reference

12 December 2020

Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression

1 reference

12 December 2020

Impact of psychostimulants on vesicular monoamine transporter function

1 reference

12 December 2020

5-HT2C receptor agonists as potential drugs for the treatment of obesity

1 reference

12 December 2020

Emerging evidence for a central epinephrine-innervated alpha 1-adrenergic system that regulates behavioral activation and is impaired in depression

1 reference

12 December 2020

The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding

1 reference

12 December 2020

Enantioselective behavioral effects of sibutramine metabolites

1 reference

12 December 2020

The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) and 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in man.

1 reference

12 December 2020

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity.

1 reference

12 December 2020

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

12 December 2020

Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine

1 reference

12 December 2020

Bioavailability in man of phendimetrazine from various dosage forms [proceedings]

1 reference

12 December 2020

Thermogenic effects of sibutramine and its metabolites

1 reference

12 December 2020

The discovery and status of sibutramine as an anti-obesity drug

1 reference

12 December 2020

Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity

1 reference

12 December 2020

WHO Expert Committee on Drug Dependence

1 reference

12 December 2020

A renaissance in trace amines inspired by a novel GPCR family

1 reference

12 December 2020

Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography

1 reference

12 December 2020

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine

1 reference

12 December 2020

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists

1 reference

12 December 2020

Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

1 reference

12 December 2020

The neural basis of addiction: a pathology of motivation and choice

1 reference

12 December 2020

Behavioral and biochemical investigations of bupropion metabolites

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:29:1:49

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference